HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,081-1,092 of 4,505
Behavioral study icon
Active Not RecruitingNCT06474195

Cue-based Intervention in Prospective Memory and Medication Adherence.

Official study title

Effectiveness of Cue-based Intervention in Improving Prospective Memory by Enhancing Medication Adherence in Patients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial

This study is no longer accepting new participants.

In Bengaluru
SchizophreniaBehavioural studyAges 18–60
Countries
India
Sponsor
University of Pittsburgh
Behavioral study icon
CompletedNCT01152697

Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic

Official study title

A Prospective Trial of Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic (CAE-L) in Individuals With Schizophrenia or Schizoaffective Disorder at Risk for Treatment Non-adherence and for Homelessness

This study has finished and is no longer accepting participants.

In Cleveland
SchizophreniaMedication studyAges 18+
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Behavioral study icon
CompletedNCT05716802

Dance/Movement Therapy for Bone Mineral Density in Schizophrenia

Official study title

Dance/Movement Therapy for Improving Bone Mineral Density in Long-term Patients With Schizophrenia: a Randomized Controlled Trial

This study has finished and is no longer accepting participants.

In Baoding
SchizophreniaBehavioural studyAges 40–60
Countries
China
Sponsor
Hebei Province Veterans Hospital
Device study icon
Active Not RecruitingNCT05337904

Deep Brain Stimulation Recovery in Treatment-Resistant Schizophrenia

Official study title

Deep Brain Stimulation: Towards a Novel Intervention Focused on the Recovery of Patients With Treatment-Resistant Schizophrenia: Randomized, Controlled, Crossover Pilot Study

This study is no longer accepting new participants.

In Barcelona
SchizophreniaDevice studyAges 18–50
Countries
Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Drug study icon
CompletedNCT05944510

Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia

Official study title

Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia: A Randomized, Group Sequential Adaptive Design, Controlled Clinical Trial

This study has finished and is no longer accepting participants.

In Bhubaneswar
SchizophreniaMedication studyAges 18+
Countries
India
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Drug study icon
CompletedNCT01082289

Digoxin Drug-Drug Interaction With Lurasidone HCl

Official study title

A Phase 1, Open-Label, Drug-Drug Interaction Study to Determine the Effect of Repeated Dose Lurasidone 120 mg Administration on the Pharmacokinetics of Orally Administered Digoxin 0.25 mg in Patients With Schizophrenia or Schizoaffective Disorder.

This study has finished and is no longer accepting participants.

In Culver City
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Behavioral study icon
CompletedNCT02782091

Discriminant Validity of the Multiple Errands Test in Schizophrenia

Official study title

Validation of an Ecological Assessment of Executive Function (Multiple Errands Test) in Patients With Schizophrenia : Study of Discriminant Validity

This study has finished and is no longer accepting participants.

In Créteil
SchizophreniaBehavioural studyAges 18–50
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.